COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2012 Jakob Stokholm, MD, PhD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
Home Home Dissemination Theses 2012 Jakob Stokholm, MD, PhD

Antibiotic Administration and Factors Influencing the Vaginal Microbiota during Pregnancy

By Jakob Stokholm, MD, PhD

Summary

Chairman: Freddy Karup Pedersen

Opponent: Agnes Wold

Opponent: Niels Frimodt Møller

(PDF)

The commensal flora consists of non-pathogenic microbiota found on all body surfaces maintaining a well-balanced host-microbial symbiotic state.

The vaginal microbiota represents a microbial ecosystem. A low pH level is maintained by acid producing bacteria, most often dominated by Lactobacillus. The low pH level is together with the host immunity responsible for protection of the vagina. A vast number of other bacterial species are represented in the vaginal commensal microbiota and among these both Staphylococcus and E. coli are often found. Skewing of the vaginal commensal flora with a following increase in pH level can lead to an overgrowth of certain microbiota resulting in bacterial vaginosis or vaginal candidiasis.

Humans are continuously exposed to a large amount of environmental factors providing a possible influence on their microbial ecology. Antibiotic administration is one of the factors with the ability to promote such changes. Household pets are another contributor which can potentially affect the microbiota of the owner.

The aim of this PhD thesis was to investigate the factors affecting the antibiotic usage and vaginal microbiota in pregnant women from the COPSAC2010 pregnancy cohort.

In study I, we described the usage of antibiotics; (1) in pregnancy as oral antibiotics subdivided into groups; urinary tract infection (UTI) antibiotics, beta-lactams and other antibiotics, and (2) during birth as intrapartum antibiotics. Furthermore we examined whether the usage of both oral antibiotics during pregnancy and intrapartum antibiotics was associated to social and lifestyle-factors. The prevalence of oral antibiotic administration during pregnancywas higher than a decade ago with more than one-third of pregnant women being treated. Oral antibiotic administration as well as multiple antibiotic treatments was increased in the lower educated women. Younger women and smokers had an increased usage of UTI antibiotics and asthmatic women had an increased usage of beta-lactams. Administration of intrapartum antibiotics was increased in smokers, in women giving birth at a lower gestational age, and in women with a lower parity. These predictors for antibiotic administration may be used as general health indicators.

In study II, we analyzed the effect of antibiotic administration during pregnancy on the commensal vaginal microbiota. Vaginal samples were cultured at 36th week of pregnancy and described at genus level. Most dominating genus was Staphylococcus spp. which colonized 79% of the women.  Oral antibiotic usage both at any time-point during pregnancy and during third pregnancy trimester was associated to an increased rate of vaginal colonization by Staphylococcus spp. These bacteriological changes were associated to treatment with UTI antibiotics. Women treated in the third trimester of pregnancy were more often colonized by E. coli. This change was associated to beta-lactam treatment. We did not observe any significant changes in vaginal group B Streptococcus (GBS) following antibiotic treatment in pregnancy.A changed vaginal flora in pregnant women may lead to infections with potential morbidity to woman and fetus.

In study III, we studied the associations between exposure to cat and dog during pregnancy and the vaginal bacterial flora at 36th week of pregnancy, antibiotic usage, and self-reported infections in pregnancy. We aimed to examine whether living with a cat or a dog was able to affect the vaginal flora, and prevalence of infections. Living with cat or dog in the home was significantly associated to increased vaginal colonization with E. coli, increased administration of antibiotics and increased prevalence of UTI in pregnancy. All estimates were adjusted for environmental and social factors. We suggest that transmission of bacteria from pet to owner is responsible for the associations to vaginal E. coli, oral antibiotic use, and UTI. Our study suggests a clinically important transmission of pathogenic bacteria from pet to owner.

In conclusion, we have found that Danish women present a high intake of antibiotics during pregnancy, and that both oral antibiotic usage during pregnancy and intrapartum antibiotic administration is influenced by social and lifestyle related factors. Antibiotic usage during pregnancy and especially in third trimester has the ability to cause alterations in the vaginal ecology at 36th week of pregnancy. Furthermore, both the vaginal flora and antibiotic usage during pregnancy is affected by having a cat or dog at home. A changed vaginal flora in pregnant women may potentially lead to intrauterine infection, UTI, preterm birth, neonatal infection and effects on theearly microbial colonization of the neonate. Likewise, it is suggested, that a transmission of pathogenic bacteria from pet to owner poses a clinical important threat, which can lead to infection in pregnant women.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC